BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38625902)

  • 1. Interpreter usage and associations with latent tuberculosis infection treatment acceptance and completion in the USA among non-U.S.-born persons, 2012-2017.
    Gonzalez-Reyes R; Katz D; Lambert L; Sorri Y; Narita M; Horne DJ;
    PLoS One; 2024; 19(4):e0298628. PubMed ID: 38625902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of latent tuberculosis treatment initiation and completion at a U.S. public health clinic: a prospective cohort study.
    Goswami ND; Gadkowski LB; Piedrahita C; Bissette D; Ahearn MA; Blain ML; Østbye T; Saukkonen J; Stout JE
    BMC Public Health; 2012 Jun; 12():468. PubMed ID: 22720842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada.
    Colson PW; Hirsch-Moverman Y; Bethel J; Vempaty P; Salcedo K; Wall K; Miranda W; Collins S; Horsburgh CR;
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):473-9. PubMed ID: 23485381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States.
    Holzman SB; Perry A; Saleeb P; Pyan A; Keh C; Salcedo K; Narita M; Ahmed A; Miller TL; Pettit AC; Khurana R; Whipple M; Katz D; Largen A; Krueger A; Shah M;
    Clin Infect Dis; 2022 Nov; 75(10):1792-1799. PubMed ID: 35363249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional study of latent tuberculosis infection, insurance coverage, and usual sources of health care among non-US-born persons in the United States.
    Annan E; Stockbridge EL; Katz D; Mun EY; Miller TL
    Medicine (Baltimore); 2021 Feb; 100(7):e24838. PubMed ID: 33607853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated Latent Tuberculosis Infection Prevalence and Tuberculosis Reactivation Rates Among Non-U.S.-Born Residents in the United States, from the 2011-2012 National Health and Nutrition Examination Survey.
    Yelk Woodruff R; Hill A; Marks S; Navin T; Miramontes R
    J Immigr Minor Health; 2021 Aug; 23(4):806-812. PubMed ID: 32761297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.
    Schein YL; Madebo T; Andersen HE; Arnesen TM; Dyrhol-Riise AM; Tveiten H; White RA; Winje BA
    BMC Infect Dis; 2018 Nov; 18(1):587. PubMed ID: 30453946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent Tuberculosis Infection Test Agreement in the National Health and Nutrition Examination Survey.
    Ghassemieh BJ; Attia EF; Koelle DM; Mancuso JD; Narita M; Horne DJ
    Am J Respir Crit Care Med; 2016 Aug; 194(4):493-500. PubMed ID: 26890477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model.
    Tasillo A; Salomon JA; Trikalinos TA; Horsburgh CR; Marks SM; Linas BP
    JAMA Intern Med; 2017 Dec; 177(12):1755-1764. PubMed ID: 29049814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prevalence of Latent Tuberculosis Infection in the United States.
    Mancuso JD; Diffenderfer JM; Ghassemieh BJ; Horne DJ; Kao TC
    Am J Respir Crit Care Med; 2016 Aug; 194(4):501-9. PubMed ID: 26866439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can Primary Care Drive Tuberculosis Elimination? Increasing Latent Tuberculosis Infection Testing and Treatment Initiation at a Community Health Center with a Large Non-U.S.-born Population.
    Tang AS; Mochizuki T; Dong Z; Flood J; Katrak SS
    J Immigr Minor Health; 2023 Aug; 25(4):803-815. PubMed ID: 36652151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying factors affecting latent tuberculosis treatment acceptance among healthcare workers: a retrospective analysis in a tertiary care centre.
    Bar-Meir M; Pariente G; Romem A; Wiener-Well Y
    BMJ Open; 2021 Sep; 11(9):e047444. PubMed ID: 34493512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported Engagement in Care among U.S. Residents with Latent Tuberculosis Infection: 2011-2012.
    Mancuso JD; Miramontes R; Winston CA; Horsburgh CR; Hill AN
    Ann Am Thorac Soc; 2021 Oct; 18(10):1669-1676. PubMed ID: 33684324
    [No Abstract]   [Full Text] [Related]  

  • 14. Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data.
    Kawatsu L; Uchimura K; Ohkado A
    BMC Infect Dis; 2021 Jan; 21(1):42. PubMed ID: 33422003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation and completion rates for latent tuberculosis infection treatment: a systematic review.
    Sandgren A; Vonk Noordegraaf-Schouten M; van Kessel F; Stuurman A; Oordt-Speets A; van der Werf MJ
    BMC Infect Dis; 2016 May; 16():204. PubMed ID: 27184748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High rate of latent tuberculosis treatment completion in immigrants seeking asylum in Sweden.
    Olsson O; Winqvist N; Olsson M; Olsson P; Björkman P
    Infect Dis (Lond); 2018 Sep; 50(9):678-686. PubMed ID: 29620426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis among Newly Arrived Immigrants and Refugees in the United States.
    Liu Y; Phares CR; Posey DL; Maloney SA; Cain KP; Weinberg MS; Schmit KM; Marano N; Cetron MS
    Ann Am Thorac Soc; 2020 Nov; 17(11):1401-1412. PubMed ID: 32730094
    [No Abstract]   [Full Text] [Related]  

  • 18. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.
    Sterling TR; Njie G; Zenner D; Cohn DL; Reves R; Ahmed A; Menzies D; Horsburgh CR; Crane CM; Burgos M; LoBue P; Winston CA; Belknap R
    MMWR Recomm Rep; 2020 Feb; 69(1):1-11. PubMed ID: 32053584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.
    Mirzazadeh A; Kahn JG; Haddad MB; Hill AN; Marks SM; Readhead A; Barry PM; Flood J; Mermin JH; Shete PB
    PLoS One; 2021; 16(4):e0249012. PubMed ID: 33793612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community treatment of latent tuberculosis in child and adult refugee populations: outcomes and successes.
    Harwood-Johnson E; Leis KS; Hanson J; Olfert J; Blonde Y; Brindamour M
    Front Public Health; 2023; 11():1225217. PubMed ID: 37942244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.